Discovery Pipeline

Mar 16, 2017
By BioPharm International Editors
Human antibody for Zika virus could help in the treatment and prevention of the infection.
Feb 14, 2017
Evaluate and BioPharm International highlight the antibody-based therapeutics that may have 2017 launch dates in the United States.
Feb 13, 2017
EvaluatePharma and BioPharm International highlight the antibody-based therapeutics that may gain United States Regulatory approval in 2017.
Nov 04, 2016
By BioPharm International Editors
Researchers in the University of Dundee have discovered a new method of activating drugs to combat visceral leishmaniasis. The discovery could lead to better treatments for neglected tropical diseases.
Jan 28, 2016
BioPharm International
The body’s over-editing of synaptic interactions is recognized as a probable cause of schizophrenia in a landmark study.
Dec 04, 2015
By BioPharm International Editors
Scientists at Rice University have developed a method to control the infectivity of viruses and gene delivery to the nuclei of target cells.
Sep 25, 2015
By BioPharm International Editors
MedImmune and 3M Drug Delivery Systems collaborate to develop toll-like receptor (TLR) agonists for immuno-oncology.
Sep 22, 2015
By BioPharm International Editors
Six grants from the NIH will help identify variants in the genome’s regulatory regions that affect disease risk, using new computational approaches.
Jun 18, 2015
By BioPharm International Editors
GSK announces it will invest $95 million to launch a US-based non-profit research institute, Altius, to research technologies and approaches in understanding gene control.
Mar 17, 2015
BioPharm International
Treatment with monoclonal antibodies that inhibit the activity of PCSK9 was shown to significantly lower LDL cholesterol levels and have a strong cardiovascular benefit.
native1_300x100
lorem ipsum